WoodChuck.ai | $3,750,000 | (Jul 1, 2025)
Tandem Health | $50,000,000 | (Jul 1, 2025)
LogicFlo AI | $2,700,000 | (Jul 1, 2025)
Certified by Founder
Lodge
GC Therapeutics
start up
United States
- Cambridge, MA
- 24/09/2024
- Series A
- $65,000,000
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases.
The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.
- Industry Biotechnology Research
- Website https://www.gc-tx.com/
- LinkedIn https://www.linkedin.com/company/gctx/
North.cloud | $5,000,000 | (Jul 1, 2025)
CRED(US) | $15,000,000 | (Jul 1, 2025)
Vellum Health | Undisclosed Amount | (Jul 1, 2025)
Clearspeed | $60,000,000 | (Jul 1, 2025)
RevEng.AI | $4,150,000 | (Jul 1, 2025)
Foresight(US) | $5,500,000 | (Jul 1, 2025)
NiaHealth | $5,750,000 | (Jul 1, 2025)
Skarbe | $600,000 | (Jul 1, 2025)
Nascent Materials | $3,200,000 | (Jul 1, 2025)